International Myeloma Foundation
MYELOMA MINUTE | Up To The Minute News | 11.12.2020
female doctor working with pathogen samples
ASH 2020: Building Toward the Future of Myeloma Care
Which research findings at this year’s American Society of Hematology meeting will impact myeloma the most? IMF Chairman Dr. Brian G.M. Durie shares his Top 10 ASH abstracts.
read the blog
Doctor reading clinical trials paper
Phase III Boston Trial Results Published in The Lancet
Phase III BOSTON (bortezomib, selinexor, and dexamethasone) study results have been published online in The Lancet. This study evaluates XPOVIO® (selinexor) in patients with relapsed or refractory multiple myeloma. In particular “the BOSTON study evaluated once weekly XPOVIO....a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound, in combination with once weekly Velcade® (bortezomib) and low-dose dexamethasone against standard twice weekly Velcade in adult patients with multiple myeloma who had received one to three prior lines of therapy.”
Tiffany Williams podcast
Listen Now to “A Day in the Life” Podcast with Guest Tiffany Williams 
In this episode of “A Day in the Life” podcast, seven-year myeloma survivor Tiffany Williams talks about what it means to live well with myeloma, even during a pandemic. She says, “Although it’s scary, I’m recognizing blessings every single day. And I’m making a conscious effort to call them out.” Listen now for your dose of inspiration. 
regional community workshop panel speakers
Register NOW for This IMF Virtual Regional Community Workshop
An IMF Virtual Southwest Regional Community Workshop will take place at 9 a.m. PT / 10 a.m. MT on Saturday, November 14. Speakers include Dr. Joseph Mikhael of Translational Genomics Research Institute (TGen); Nina Shah, MD of the University of California San Francisco (UCSF) Health; and Kimberly Noonan, RN, ANP, AOCN, and a member of the IMF’s Nurse Leadership Board. Key topics include myeloma 101, frontline therapy, relapsed myeloma, emerging therapies, and more. Participants will be able to ask questions of the panel of experts.
register button
charity buzz auction promotion
Bid on Exclusive Items at Charitybuzz and Give to the IMF
As part of our 14th Annual Virtual Comedy Celebration, the IMF is hosting an auction of amazing items on Charitybuzz. Top-of-the-line auction items have been announced and are open for bidding from November 17th until December 3rd. Choose from such items as a Virtual Tea with Slava Rubin, Founder and Managing Director of Indiegogo and Founder of humbition; a Virtual Fashion Consultation with Bobbi Thomas, Style Editor for NBC’s “TODAY” show; and more!
bid now
accelerating toward curing myeloma registration
Register NOW for the 2020 American Society of Hematology’s Virtual Symposium
In partnership with Clinical Care Options LLC, the International Myeloma Foundation presents the webinar “Accelerating Toward Curing Myeloma: New Data, New Agents, and Evolving Treatment Paradigm,” on Friday, December 4 at 11 a.m. PT / 1 p.m. CT / 2 p.m. ET. The expert panel includes IMF Chairman of the Board Dr. Brian G.M. Durie (Cedars-Sinai — Los Angeles), Dr. Thomas G. Martin (University of San Francisco — San Francisco), Dr. Philippe Moreau (University Hospital — Nantes, France), Dr. S. Vincent Rajkumar (Mayo Clinic — Rochester, Minnesota), and Dr. Jesús San Miguel (Universidad de Navarra — Pamplona, Spain). For healthcare professionals, a CME/CE-activity is available upon completion of the webinar.
register button
hawaii beach house
And This Too Shall Pass…. 
Once again, the IMF is hosting a raffle for a 10-day stay at the Villa Ono Oasis in historic Kailua-Kona, Hawaii. While many of us have been affected by COVID-19, we hope to remind you that this too shall pass. If you purchase the winning $50 raffle ticket, you could find yourself just minutes from the Hawaiian coastline. The winner will be announced on April 2, 2021. Note: Bookings will be in the future based on mutual availability with you and the property owner. 
learn more
ask doctor durie video image
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
This Week’s Question:

For myeloma patients, how important is it to wear a mask? 
Watch Now
Clinical Trials
OCEAN Trial (Fully Accrued)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)
Search the Myeloma Matrix 2.0

Smart Patients: Join the Conversation
Upcoming Events
Watch the Replay
IMF Patient & Family Webinar

Learn More
Winter Challenge

Bid Now
Hawaiian Raffle

Click here to see all events

We Thank Our Sponsors:

Amgen; Bristol-Myers Squibb; Genentech; GSK; Oncopeptides, Inc.; Sanofi-Genzyme; and Takeda Oncology
We also thank individuals like you for your continued support!
Subscribe Button@2x.jpg
Join the conversation at The International Myeloma Foundation
Facebook Facebook: /Myeloma  |  Twitter Twitter @IMFMyeloma  |  Instagram Instagram @IMFmyeloma
This email was sent by:
The International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
Connect with the IMF InfoLine
We respect your privacy and your preferences for communications of this nature.
Home  •  Unsubscribe  •  Privacy Policy
View as web page